RECURRENT OVARIAN CARCINOSARCOMA

Clinical trials for RECURRENT OVARIAN CARCINOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OVARIAN CARCINOSARCOMA trials appear

Sign up with your email to follow new studies for RECURRENT OVARIAN CARCINOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for Tough-to-Treat ovarian cancers in early trial

Disease control Ongoing

This early-stage study is testing a new two-drug combination for women with ovarian cancer that has returned after previous treatment. The main goal is to find the safest and most effective dose of an experimental pill (peposertib) when given with a standard chemotherapy drug. Re…

Matched conditions: RECURRENT OVARIAN CARCINOSARCOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

RECURRENT OVARIAN CARCINOSARCOMA

Get alerted when new RECURRENT OVARIAN CARCINOSARCOMA trials appear

New hope for Tough-to-Treat ovarian cancers in early trial